Comparison

Atezolizumab

Item no. DCC-A004-10mg
Manufacturer DCChemicals
CASRN 1380723-44-3
Amount 10 mg
Category
Type Chemicals
Specific against other
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Alias </td></tr><tr><th>MW</th><td colspan="7">Therapeutic Antibodies
Similar products 1380723-44-3
Available
Field of Application
Atezolizumab (anti-PD-L1) is a fully humanized, IgG1 monoclonal antibody that blocks the interaction of PD-L1 with both PD-1 and B7.1, but not the interaction of PD-L2 with PD-1.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close